Loading…
Underlying
Underlying Price
$8.28
Type
Put
Strike
5.5
Expiration
Oct 30, 2026
DTE
10d
Moneyness
OTM
Intrinsic
$0.00
IBRX 5.5 Put Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 23, 2026 | 3d | — | — | 0 | 0 |
| Oct 30, 2026 | 10d | — | — | 0 | 0 |
| Nov 6, 2026 | 17d | — | — | 0 | 0 |
| Nov 13, 2026 | 24d | — | — | 0 | 0 |
| Nov 27, 2026 | 38d | — | — | 0 | 0 |
| Jan 15, 2027 | 87d | $0.30 | -14.29% | 30 | 34,106 |
| Jan 21, 2028 | 458d | $1.58 | +17.04% | 10 | 3,931 |
IBRX Profile
immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.